stockrow
Saturday 7 November 2026
Export MPT’s income statement to Excel — free account
Medical Properties Trust, Inc.
MPT Real Estate Reit Healthcare Facilities
Medical Properties Trust, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $972.0 million, down 2.36% from fiscal 2024.
- Revenue
- +5.31%
- EPS
- +360.3%
- Free cash flow
- −15.2%
- Total debt
- −3.70%
Quarter to September 2026, against a year earlier
1.80
0.08
−4.26%
Follow MPT
Alert me
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
P/E ratio |
+8 more quarters Free account |
0.00 | 0.00 | 0.00 | 8.35 |
P/S ratio |
3.09 | 2.77 | 2.71 | 2.00 | |
P/FCF ratio |
11.07 | 10.30 | 10.68 | 7.98 | |
P/Operating CF |
18.77 | (194.08) | 44.24 | 33.09 | |
P/B ratio |
0.65 | 0.61 | 0.61 | 0.45 | |
Price to Tangible BV |
0.65 | 0.61 | 0.61 | 0.45 | |
EV/Sales |
12.51 | 12.00 | 11.84 | 10.40 | |
EV/EBITDA |
37.02 | 34.30 | 33.81 | 30.05 | |
EV/Operating CF |
52.70 | 55.55 | 53.22 | 47.29 | |
EV/FCF |
44.82 | 44.68 | 46.65 | 41.45 | |
Quick Ratio |
2.63 | 3.11 | 3.12 | 3.92 | |
Current Ratio |
2.63 | 3.11 | 3.12 | 3.92 | |
Net Debt/EBITDA |
80.86 | 105.93 | 104.84 | 0.00 | |
Debt/Assets |
64.64% | 65.45% | 65.81% | 64.34% | |
Debt/Equity |
2.10 | 2.13 | 2.16 | 2.00 | |
Asset Turnover |
0.07 | 0.07 | 0.07 | 0.07 | |
Operating CF/Net income |
9.25 | (0.43) | (24.06) | 0.00 | |
Capex/Depreciation |
0.06 | 0.07 | (0.09) | — | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
9.09% | 12.78% | 13.41% | 11.61% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
(1.89%) | 0.23% | 1.87% | 0.00% | |
Graham Net Nets |
(2.98) | (3.21) | (3.22) | (3.97) | |
Graham Number |
0.00 | 0.00 | 0.00 | 8.50 | |
Earnings Yield |
(9.20%) | (4.54%) | (1.16%) | 11.98% | |
Free Cash Flow Yield |
9.03% | 9.71% | 9.37% | 12.52% | |
Revenue per Share |
0.45 | 0.42 | 0.43 | 0.42 | |
Operating CF per Share |
0.27 | (0.02) | 0.10 | 0.00 | |
Capex per Share |
0.01 | 0.01 | (0.01) | 0.00 | |
Free Cash Flow per Share |
0.27 | (0.01) | 0.09 | 0.00 | |
Cash per Share |
0.90 | 0.71 | 0.66 | 1.00 | |
Shareholders Equity per Share |
7.67 | 7.61 | 7.53 | 7.74 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
7.67 | 7.61 | 7.53 | 7.74 | |
Free Cash Flow |
164.40 | (8.48) | 55.37 | — | |
Working Capital |
892.42 | 913.89 | 912.33 | 1,164.04 | |
Capital Expenditures |
4.33 | 5.78 | (7.07) | — | |
Net Current Asset Value |
(8,953.01) | (8,869.86) | (8,905.43) | (8,208.52) | |
EV/EBIT |
413.47 | 287.16 | 277.32 | 279.41 | |
Capex to Sales |
(0.02) | (0.02) | 0.03 | 0.00 | |
Price to Operating Income |
102.15 | 66.20 | 63.47 | 53.82 | |
| Other line items | |||||
Average Receivables |
818.89 | 852.17 | 900.17 | 920.18 | |
Average Payables |
501.66 | 442.22 | 462.43 | 437.32 | |
Average Assets |
14,648.19 | 14,808.28 | 14,949.09 | 14,658.95 | |
Average Common Equity |
4,720.52 | 4,653.92 | 4,666.86 | 4,641.89 |
Columns are period end dates · fundamentals updated 2 Nov 2026